Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Institute, National Research Institute, Dokki, Cairo 12622, Egypt.
Chemistry Department, Faculty of Science, South Valley University, Qena 83523, Egypt.
Molecules. 2021 Nov 25;26(23):7119. doi: 10.3390/molecules26237119.
2-azido-1-benzo[d]imidazole derivatives , were reacted with a β-ketoester such as acetylacetone in the presence of sodium ethoxide to obtain the desired molecules ,. The latter acted as a key molecule for the synthesis of new carbazone derivatives , that were submitted to react with 2-oxo--phenyl-2-(phenylamino)acetohydrazonoyl chloride to obtain the target thiadiazole derivatives ,. The structures of the newly synthesized compounds were inferred from correct spectral and microanalytical data. Moreover, the newly prepared compounds were subjected to molecular docking studies with DNA gyrase B and exhibited binding energy that extended from -9.8 to -6.4 kcal/mol, which confirmed their excellent potency. The compounds , were found to be with the minimum binding energy (-9.7 and -9.8 kcal/mol) as compared to the standard drug ciprofloxacin (-7.4 kcal/mol) against the target enzyme DNA gyrase B. In addition, the newly synthesized compounds were also examined and screened for their in vitro antimicrobial activity against pathogenic microorganisms , , , and . Among the newly synthesized molecules, significant antimicrobial activity against all the tested microorganisms was obtained for the compounds ,. The in silico and in vitro findings showed that compounds , were the most active against bacterial strains, and could serve as potential antimicrobial agents.
2-叠氮-1-苯并[d]咪唑衍生物与β-二酮酯(如乙酰丙酮)在乙醇钠存在下反应,得到所需的分子。后者作为合成新的卡巴唑衍生物的关键分子,与 2-氧代--苯基-2-(苯基氨基)乙酰腙酰氯反应,得到目标噻二唑衍生物。新合成化合物的结构是从正确的光谱和微量分析数据推断出来的。此外,新制备的化合物进行了与 DNA 拓扑异构酶 B 的分子对接研究,表现出从-9.8 到-6.4 kcal/mol 的结合能,证实了它们的优异效力。与标准药物环丙沙星(-7.4 kcal/mol)相比,化合物、的最低结合能(-9.7 和-9.8 kcal/mol),对靶酶 DNA 拓扑异构酶 B 具有更好的活性。此外,还对新合成的化合物进行了体外抗微生物活性测试,包括对致病性微生物、、、的抑制作用。在新合成的分子中,化合物、对所有测试的微生物都表现出显著的抗菌活性。体内和体外的研究结果表明,化合物、对细菌菌株最具活性,可作为潜在的抗菌药物。